#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Chronic myeloid leukaemia Acquired haemophilia Postprandial hypoglycaemia Paget's disease of the vulva Chronic granulomatous disease Monogenic diabetes Antiphospholipid syndrome Hereditary optic atrophy Cystic fibrosis lung Desmoplastic small round cell tumour Immune-mediated myositis Leukocyte adhesion deficiency Hepatic angiosarcoma Enteritis More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Diagnostics Chronic granulomatous disease – Treatment Von Willebrand’s disease – Basic Information Glycogen storage disease type II – Basic Information Haemolytic uraemic syndrome – Treatment Angiosarcoma – Life with Disease Primary hyperoxaluria – Diagnostics Antisynthetase syndrome – Basic Information Vascular malformation – Basic Information Progressive supranuclear palsy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eftrenonacog Alfa Taminadenant SAROGLITAZAR HEMIMAGNESIUM Prasinezumab Flecainide Acetate Piperacillin Monohydrate Bezafibrate Dactylis Glomerata Zongertinib Verapamil Lisinopril Tpst-1120 Hydrocortisone Tolcapone Gremubamab HLX43 Tumour Detection Epirubicin Isatuximab Nacubactam More therapies…

    Learn about Your Condition

    Graft versus host disease Hypoparathyroidism Alcoholism Lymphoma Bone marrow disorder Loeys-Dietz syndrome Combined immunodeficiency Autism spectrum disorder Tubulointerstitial nephritis Ehlers-Danlos syndrome Kaposi's sarcoma Psoriasis Syphilis Somatic symptom disorder Exposure via breast milk More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki W Krakowie

Szpital Uniwersytecki W Krakowie

ul. Jakubowskiego 2, Cracow, Krakow, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Stress cardiomyopathy
    Investigated Drugs:
    • Glucose Monohydrate
    • Levosimendan
    Poland

  • Study on Atorvastatin for Reducing COPD Exacerbations in Smokers with Chronic Obstructive Pulmonary Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Atorvastatin
    Poland

  • Study of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • DESMOPRESSIN ACETATE
    Poland

  • Study of Lu AG13909 in Adults with Cushing’s Disease to Evaluate Safety and Effectiveness

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pituitary-dependent Cushing’s syndrome
    Investigated Drugs:
    • Ag13909
    France Hungary Italy Poland Romania Spain

  • Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Naproxen
    • Tofacitinib
    Bulgaria Czechia Germany Poland

  • Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Evolocumab
    France Germany Italy Poland Spain
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!